Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1979-2-12
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1196-210
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:719172-Bone Marrow Cells,
pubmed-meshheading:719172-Colony-Forming Units Assay,
pubmed-meshheading:719172-Dose-Response Relationship, Drug,
pubmed-meshheading:719172-Erythropoiesis,
pubmed-meshheading:719172-Erythropoietin,
pubmed-meshheading:719172-Humans,
pubmed-meshheading:719172-Polycythemia Vera
|
pubmed:year |
1978
|
pubmed:articleTitle |
Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera.
|
pubmed:publicationType |
Journal Article
|